Mail

Canada markets close in 39 minutes

S&P/TSX
22,292.55
+49.21(+0.22%)
S&P 500
5,303.76
+57.08(+1.09%)
DOW
39,861.65
+303.54(+0.77%)
CAD/USD
0.7351
+0.0026(+0.35%)
CRUDE OIL
78.85
+0.83(+1.06%)
Bitcoin CAD
89,320.65
+5,699.47(+6.82%)

MARKETS LIVE BLOG

STOCKS JUMP AFTER U.S. INFLATION REPORT RELEASE

Roundhill Magnificent Seven ETF hits all-time high on Wednesday

BioNexus Gene Lab Corp. (BGLC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

0.5850

+0.0037

(+0.64%)

As of 03:00PM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	10.30M
Enterprise Value	4.50M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.95
Price/Book (mrq)	1.07
Enterprise Value/Revenue	0.46
Enterprise Value/EBITDA	804.94

Trading Information

Stock Price History

Beta (5Y Monthly)	1.95
52-Week Change ³	84.49%
S&P500 52-Week Change ³	26.16%
52 Week High ³	9.4900
52 Week Low ³	0.0800
50-Day Moving Average ³	0.6647
200-Day Moving Average ³	0.7540

Share Statistics

Avg Vol (3 month) ³	251.17k
Avg Vol (10 day) ³	59.1k
Shares Outstanding ⁵	17.67M
Implied Shares Outstanding ⁶	17.67M
Float ⁸	9.96M
% Held by Insiders ¹	64.38%
% Held by Institutions ¹	0.76%
Shares Short (Apr 30, 2024) ⁴	176.54k
Short Ratio (Apr 30, 2024) ⁴	0.65
Short % of Float (Apr 30, 2024) ⁴	1.03%
Short % of Shares Outstanding (Apr 30, 2024) ⁴	1.00%
Shares Short (prior month Mar 28, 2024) ⁴	43.36k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2023

Profitability

Profit Margin	-26.91%
Operating Margin (ttm)	7.36%

Management Effectiveness

Return on Assets (ttm)	-12.68%
Return on Equity (ttm)	-32.21%

Income Statement

Revenue (ttm)	9.77M
Revenue Per Share (ttm)	0.62
Quarterly Revenue Growth (yoy)	-20.00%
Gross Profit (ttm)	N/A
EBITDA	-1.96M
Net Income Avi to Common (ttm)	-2.63M
Diluted EPS (ttm)	-0.1800
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	5.93M
Total Cash Per Share (mrq)	0.34
Total Debt (mrq)	146.59k
Total Debt/Equity (mrq)	1.52%
Current Ratio (mrq)	4.93
Book Value Per Share (mrq)	0.55

Cash Flow Statement

Operating Cash Flow (ttm)	-1.3M
Levered Free Cash Flow (ttm)	566.75k